Key Market Insights

• Presently, over 255 companies have the required expertise to manufacture various types of bioreactors and fermenters across the globe
• The current market landscape is dominated by the presence of start-ups / small companies (up to 50 employees) and mid-sized companies (51-500 employees), which collectively represent over 90% of the total number of bioreactor and fermenter manufacturers.
• Close to 80% firms manufacture bioreactors and fermenters for batch processes; of these, 55% of the manufacturers have the capability to scale-up their equipment from lab to commercial scale
• The bioreactors and fermenters market landscape is fragmented; most of the well-established players are located in developed regions, while majority of small players are located in the Asia-Pacific region
• The emergence of COVID-19 in the recent past led to a surge in demand for complex biologics and subsequently the requirement of novel bioreactors and fermenters; these developments prompted several bioreactor and fermenter manufacturers to upgrade their capabilities
• The global installed bioreactors and fermenters capacity is distributed across various geographies; over 60% of this capacity is installed in the in-house facilities of biologics manufacturers
• Stainless steel bioreactors hold a prominent share (~90%) of the current installed biomanufacturing capacity; majority of this is dedicated to the manufacturing of mammalian and microbial based therapeutics
• The global bioreactors and fermenters market is likely to grow at a CAGR of ~11%, till 2035; the projected opportunity is likely to be driven by continuous manufacturing bioprocesses
• In the long term, the disposable / single-use systems used for the manufacturing of antibodies and other novel biologics are likely to emerge as the key growth drivers of the overall market

Table of Contents

1. PREFACE
   1.1. Introduction
   1.2.      Key Market Insights
   1.3.      Scope of the Report
   1.4.      Research Methodology
   1.5.      Frequently Asked Questions

1.6.      Chapter Outlines

2. 
   EXECUTIVE SUMMARY

3. INTRODUCTION
   3.1. Chapter Overview

3.2.      Overview of Bioreactors

3.3.      Components of a Bioreactor

3.4.      Types of Bioreactors

3.5.      Applications of Bioreactors

3.6.      Future Perspectives

4. BIOREACTOR AND FERMENTER MANUFACTURERS: MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.      Bioreactor and Fermenter Manufacturers: Overall Market Landscape

5. COMPANY COMPETITIVENESS ANALYSIS

5.1.      Chapter Overview

5.2.      Assumptions / Key Parameters

5.3.      Methodology

5.4.      Company Competitiveness Analysis: Small Companies

5.5.      Company Competitiveness Analysis: Mid-sized Companies

5.6.      Company Competitiveness Analysis: Large and Very Large Companies

6. COMPANY PROFILES

6.1.      Chapter Overview

6.2.      Applikon Biotechnology (Acquired by Getinge)

6.2.1.   Company Overview

6.2.2.   Product Portfolio

6.2.3.   Recent Developments and Future Outlook

6.3.      Bionet

6.4.      Cytiva

6.5.      Eppendorf

6.6.      Merck

6.7.      Ollital Technology

6.8.      Parr Instrument Company

6.9.      Sartorius

6.10.    Shanghai Bailun Biological Technology

6.11.    Solaris Biotech

6.12.    Solida Biotech

6.13.    Zhengzhou Laboao Instrument Equipment (LABAO)

7. CAPACITY ANALYSIS

7.1.      Chapter Overview

7.2.      Key Assumptions and Methodology

7.3.      Concluding Remarks

8. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS

8.1.      Chapter Overview

8.2.      Bioprocess Control Software: Overall Market Landscape

8.3.      Bioprocess Control Software Developers: Overall Market Landscape

8.4.      Upstream Controllers: Overall Market Landscape

8.5.      Upstream Controller Developers: Overall Market Landscape

8.6.      Downstream Controller Systems: Overall Market Landscape

8.7.      Downstream Controller System Developers: Overall Market Landscape

9. MARKET SIZING AND OPPURTUNITY ANALYSIS

9.1.      Chapter Overview

9.2.      Key Assumptions and Forecast Methodology

9.3.      Global Bioreactors and Fermenters Market (Historical, Base and Forecasted Scenario), 2017-
             2035

10. CONCLUDING REMARKS

11. EXECUTIVE INSIGHTS

12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com